# Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial

> **NCT01196819** · NA · COMPLETED · sponsor: **Shanghai MicroPort Medical (Group) Co., Ltd.** · enrollment: 458 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Firehawk
- **DEVICE:** Xience V

## Key facts

- **NCT ID:** NCT01196819
- **Lead sponsor:** Shanghai MicroPort Medical (Group) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-05
- **Final completion:** 2016-12
- **Target enrollment:** 458 (ACTUAL)
- **Last updated:** 2019-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01196819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01196819, "Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01196819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*